Inventor · disambiguated record
Daniel Sohn
Also filed as: SOHN DANIEL · SOHN DANIEL D · SOHN DANIEL DUNGAN
28 granted patents·19 pending applications·190 citations·filing 1984–2025
96Inventor score
Files withASTRAZENECA AB16ASTRA AB9SEARLE & CO4GRAVENFORS YLVA2KARIN & STEN MORTSTEDT CBD SOLUTIONS AB2
Top patents by PatentIndex Score
47 records- 0186US5576429A5-substituted pyrimidine nucleosides and nucleotidesMEDIVIR AB·Filed 1995·Granted Nov 19, 1996·51 cites·14 claims
- 0286US4665203ASubstituted dihydrobenzopyrans useful as leukotriene D4 inhibitorsSEARLE & CO·Filed 1985·Granted May 12, 1987·21 cites·3 claims
- 0382US6812225B2Therapeutic heterocyclic compoundsASTRAZENECA AB·Filed 2002·Granted Nov 2, 2004·16 cites·9 claims
- 0479US8163928B2Heteroaryl substituted benzothiazolesGRAVENFORS YLVA·Filed 2007·Granted Apr 24, 2012·7 cites·10 claims
- 0577US7947693B25,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitorsASTRAZENECA AB·Filed 2006·Granted May 24, 2011·3 cites·8 claims
- 0675US4778903ASubstituted dihydrobenzopyransSEARLE & CO·Filed 1984·Granted Oct 18, 1988·9 cites·6 claims
- 0774US12304901B2Selective ligands for tau aggregatesSENTONIX INC·Filed 2024·Granted May 20, 2025·0 cites·18 claims
- 0874US7045514B2Therapeutic heterocyclic compoundsASTRAZENECA AB·Filed 2004·Granted May 16, 2006·6 cites·12 claims
- 0974US7026314B2Therapeutic chromone compoundsASTRAZENECA AB·Filed 2002·Granted Apr 11, 2006·10 cites·52 claims
- 1073US7285662B2Therapeutic heterocyclic compoundsASTRAZENECA AB·Filed 2005·Granted Oct 23, 2007·1 cites·6 claims
- 1169US8088780B25,7-disubstituted thiazolo[4,5-D]pyrimidines for the selective inhibition of chemokine receptorsNORDVALL GUNNAR·Filed 2006·Granted Jan 3, 2012·2 cites·10 claims
- 1268US7670591B2Heteroaryl substituted benzoxazolesASTRAZENECA AB·Filed 2007·Granted Mar 2, 2010·1 cites·31 claims
- 1367US8957215B2Heteroaryl substituted benzothiazolesGRAVENFORS YLVA·Filed 2012·Granted Feb 17, 2015·1 cites·29 claims
- 1467US6291458B1Morpholinobenzamide saltsASTRAZENECA AB·Filed 2000·Granted Sep 18, 2001·3 cites·20 claims
- 1567US2025289803A1Selective ligands for tau aggregatesSENTONIX INC·Filed 2025·Application pending·0 cites
- 1665US5639772AChroman derivativesASTRA AB·Filed 1995·Granted Jun 17, 1997·13 cites·13 claims
- 1763US5616610A(R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyransASTRA AB·Filed 1994·Granted Apr 1, 1997·9 cites·16 claims
- 1862US9145380B2Bis-(sulfonylamino) derivatives for use in therapyBYLUND JOHAN·Filed 2008·Granted Sep 29, 2015·1 cites·14 claims
- 1960US2008076759A1Therapeutic Heterocyclic Compounds 507ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2058US5656658AMethod for the treatment of anxietyASTRA AB·Filed 1995·Granted Aug 12, 1997·9 cites·14 claims
- 2156US4952705ASubstituted dihydrobenzopyransSEARLE & CO·Filed 1987·Granted Aug 28, 1990·4 cites·9 claims
- 2256US2011021540A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2356US2009281138A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2453US2009163586A1Bis-(Sulfonylamino) Derivatives in Therapy 205ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2552US5646309AIntermediates in the synthesis of chroman derivativesASTRA AB·Filed 1995·Granted Jul 8, 1997·5 cites·11 claims
- 2652US2005085532A1Tartrate salts of (R)-3-N,N-dicyclo-butylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamideFiled 2004·Application pending·0 cites
- 2750US5656657AChroman derivativesASTRA AB·Filed 1995·Granted Aug 12, 1997·5 cites·16 claims
- 2850US2006178372A1Therapeutic quinoline compoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2948US2009131468A1Bis-(Sulfonylamino) Derivatives in Therapy 065ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 3046US2024165276A1Selective ligands for tau aggregatesKARIN & STEN MORTSTEDT CBD SOLUTIONS AB·Filed 2020·Application pending·0 cites
- 3145US2005096312A1Therapeutic quinolone compounds with 5-ht-antagonistic propertiesFiled 2002·Application pending·0 cites
- 3245US2007142386A1New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1ASTRAZENECA·Filed 2004·Application pending·0 cites
- 3344US9440992B25,7-disubstituted thiazolo[4,5-D]pyrimidines as chemokine inhibitorsNORDVALL GUNNAR·Filed 2010·Granted Sep 13, 2016·0 cites·8 claims
- 3444US5500425AChroman derivatives and a method of treating 5-HT mediated disordersASTRA AB·Filed 1994·Granted Mar 19, 1996·3 cites·5 claims
- 3543US2009054453A1Novel Tetralins as 5-HT6 ModulatorsALCARAZ LILIAN·Filed 2007·Application pending·0 cites
- 3642US6197978B1Process for the manufacture of 3-N-N-dicyclobutylamino-8-fluoro-3, 4-dihydro-2H-1-benzopyran-5-carboxamideASTRA AB·Filed 1998·Granted Mar 6, 2001·3 cites·21 claims
- 3742US2006019947A1Therapeutic chromone compoundsCHAPDELAINE MARC·Filed 2005·Application pending·0 cites
- 3841US6858645B2Tartrate salts of (R) -3-N,N- dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1- benzopyran-5-carboxamideASTRAZENECA AB·Filed 1998·Granted Feb 22, 2005·3 cites·8 claims
- 3941US5639784AMethod for the treatment of migraineASTRA AB·Filed 1995·Granted Jun 17, 1997·2 cites·14 claims
- 4039US2005085457A1Therapeutic quinolone compounds with 5-ht-antagonistic propertiesFiled 2002·Application pending·0 cites
- 4139US2021138092A1Selective ligands for tau aggregatesKARIN & STEN MORTSTEDT CBD SOLUTIONS AB·Filed 2019·Application pending·0 cites
- 4238US2009099187A1Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 ReceptorASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4337US5641807AMethod for the treatment of depressionASTRA AB·Filed 1995·Granted Jun 24, 1997·1 cites·14 claims
- 4437US4888356AUse of substituted dihydrobenzopyrans for allergy and inflammationSEARLE & CO·Filed 1988·Granted Dec 19, 1989·1 cites·24 claims
- 4537US2009030038A1Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 ReceptorASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4636US2004082591A1Therapeutic heterocyclic compoundsFiled 2002·Application pending·0 cites
- 4736US2004110745A1Therapeutic chroman compoundsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →